Ventilation–perfusion (V/Q) lung scintigraphy performed with 99mTc-labeled agents for both phases requires careful control of the ventilation–to–perfusion count rate relationship. This is particularly important with Technegas, because efficient pulmonary deposition can produce a high
No takes yet. Share an insight, caveat, or question.
Geoffrey M. Currie (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: